OPIRANZA Trademark

Trademark Overview

On Tuesday, April 11, 2023, a trademark application was filed for OPIRANZA with the United States Patent and Trademark Office. The USPTO has given the OPIRANZA trademark a serial number of 97883560. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 27, 2025. This trademark is owned by FP Pharma Inc.. The OPIRANZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the management of opioid addiction; opioid agonist pharmaceutical preparations
opiranza

General Information

Serial Number97883560
Word MarkOPIRANZA
Filing DateTuesday, April 11, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, October 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2025

Trademark Statements

Goods and ServicesPharmaceuticals for the management of opioid addiction; opioid agonist pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFP Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6A1R8
CA

Trademark Events

Event DateEvent Description
Friday, April 14, 2023NEW APPLICATION ENTERED
Monday, April 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 5, 2024ASSIGNED TO EXAMINER
Saturday, January 13, 2024SUSPENSION LETTER WRITTEN
Saturday, January 13, 2024LETTER OF SUSPENSION E-MAILED
Saturday, January 13, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 16, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, December 17, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, December 17, 2024INQUIRY TO SUSPENSION E-MAILED
Tuesday, December 17, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, February 7, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 13, 2025ASSIGNED TO LIE
Thursday, February 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 20, 2025SUSPENSION LETTER WRITTEN
Thursday, February 20, 2025LETTER OF SUSPENSION E-MAILED
Thursday, February 20, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 21, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, September 25, 2025SUSPENSION INQUIRY WRITTEN
Thursday, September 25, 2025INQUIRY TO SUSPENSION E-MAILED
Thursday, September 25, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 26, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 17, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

opiranza opioid pharmaceutical preparations agonist addiction management pharmaceuticals